Literature DB >> 23163845

Serum albumin is superior to prealbumin for predicting short-term recurrence in patients with operable colorectal cancer.

Takaaki Fujii1, Toshinaga Sutoh, Hiroki Morita, Toshihide Katoh, Reina Yajima, Soichi Tsutsumi, Takayuki Asao, Hiroyuki Kuwano.   

Abstract

The relationship between preoperative prealbumin and cancer survival has not been fully elucidated. The purpose of this study was to examine the relationship between preoperative nutritional conditions, including prealbumin and albumin concentrations, and the risk of recurrence in cases with operable colorectal carcinoma. One hundred fifty-eight patients who underwent elective colorectal resection were analyzed in this study. Of the eligible cases, 56 (35.4%) had decreased serum prealbumin and 15 (9.5%) had decreased serum albumin preoperatively. Among 158 cases in this study, 18 (11.4%) had disease recurrence. In the univariate analysis, the depth of tumor invasion, lymph node metastasis, lymphovascular invasion, serum albumin, prealbumin, and carcinoembryonic antigen were the factors significantly associated with disease recurrence. Multivariate analysis demonstrated that only serum albumin was a predictor of the recurrence; however, serum prealbumin lost its significance on multivariate analysis. Time to tumor recurrence by Kaplan-Meier curves significantly differed among patients with low serum albumin and prealbumin level. Our results suggest that prealbumin and albumin may be sensitive indicators of the risk of recurrent disease; however, low serum albumin levels are more useful than prealbumin in predicting short-term disease recurrence in operable colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23163845     DOI: 10.1080/01635581.2012.718034

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  23 in total

1.  Implications of Low Serum Albumin as a Prognostic Factor of Long-term Outcomes in Patients With Breast Cancer.

Authors:  Takaaki Fujii; Shoko Tokuda; Yuko Nakazawa; Sasagu Kurozumi; Sayaka Obayashi; Reina Yajima; Ken Shirabe
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

2.  The Roche Immunoturbidimetric Albumin Method on Cobas c 501 Gives Higher Values Than the Abbott and Roche BCP Methods When Analyzing Patient Plasma Samples.

Authors:  Johanna Helmersson-Karlqvist; Mats Flodin; Aleksandra Mandic Havelka; Xiao Yan Xu; Anders Larsson
Journal:  J Clin Lab Anal       Date:  2016-05-12       Impact factor: 2.352

Review 3.  Implications of preoperative hypoalbuminemia in colorectal surgery.

Authors:  Adam Truong; Mark H Hanna; Zhobin Moghadamyeghaneh; Michael J Stamos
Journal:  World J Gastrointest Surg       Date:  2016-05-27

4.  Elevated pretreatment serum globulin albumin ratio predicts poor prognosis for advanced non-small cell lung cancer patients.

Authors:  Yanwen Yao; Ming Zhao; Dongmei Yuan; Xiaoling Gu; Hongbing Liu; Yong Song
Journal:  J Thorac Dis       Date:  2014-09       Impact factor: 2.895

5.  Circulating fibrinogen to pre-albumin ratio is a promising biomarker for diagnosis of colorectal cancer.

Authors:  Fan Sun; Yu-Ao Tan; Qiu-Fang Gao; Shu-Qi Li; Jing Zhang; Qing-Gen Chen; Yu-Huan Jiang; Lei Zhang; Hou-Qun Ying; Xiao-Zhong Wang
Journal:  J Clin Lab Anal       Date:  2018-07-25       Impact factor: 2.352

6.  The prognostic role of preoperative serum albumin levels in glioblastoma patients.

Authors:  Sheng Han; Yanming Huang; Zhonghua Li; Haipei Hou; Anhua Wu
Journal:  BMC Cancer       Date:  2015-03-08       Impact factor: 4.430

7.  Laparoscopic surgery contributes more to nutritional and immunologic recovery than fast-track care in colorectal cancer.

Authors:  Dong Xu; Jun Li; Yongmao Song; Jiaojiao Zhou; Fangfang Sun; Jianwei Wang; Yin Duan; Yeting Hu; Yue Liu; Xiaochen Wang; Lifeng Sun; Linshan Wu; Kefeng Ding
Journal:  World J Surg Oncol       Date:  2015-02-04       Impact factor: 2.754

8.  Pretreatment Albumin/Globulin Ratio Predicts the Prognosis for Small-Cell Lung Cancer.

Authors:  Ting Zhou; Xiaobo He; Wenfeng Fang; Jianhua Zhan; Shaodong Hong; Tao Qin; Yuxiang Ma; Jin Sheng; Ningning Zhou; Yuanyuan Zhao; Yan Huang; Li Zhang
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

9.  Prognostic impact of serum albumin levels on the recurrence of stage I non-small cell lung cancer.

Authors:  Ying Jin; Li Zhao; Fang Peng
Journal:  Clinics (Sao Paulo)       Date:  2013-05       Impact factor: 2.365

10.  The value of serum prealbumin in the diagnosis and therapeutic response of tuberculosis: a retrospective study.

Authors:  Hu Luo; Bingjing Zhu; Liang Gong; Jingxiang Yang; Yongyuan Jiang; Xiangdong Zhou
Journal:  PLoS One       Date:  2013-11-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.